|HCV NS3/4A protease|
|0.2 nM-3.5 nM|
|In vitro||DMSO||144 mg/mL (196.76 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||144 mg/mL (196.76 mM)|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||13.93 mL||69.65 mL||139.3 mL|
|0.5 mM||2.79 mL||13.93 mL||27.86 mL|
|1 mM||1.39 mL||6.96 mL||13.93 mL|
|5 mM||0.28 mL||1.39 mL||2.79 mL|
*The above data is based on the productmolecular weight 717.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||RG7227, ITMN-191, RO5190591|
Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R…
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus…
Ciluprevir is a specific and potent peptidomimetic inhibitor of the HCV NS3 protease.
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
Telaprevir (VX-950) is known as protease inhibitors that inhibits the hepatitis C virus NS3.4A serine protease.